Healthcare provider profile · identity verified

Stephen F Sipperly, D.O.

Family Practice · ALBANY, NY · NPI 1720170269

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	471	132
Omeprazole	Omeprazole	329	91
Levothyroxine Sodium	Levothyroxine Sodium	315	75
Metformin Hcl	Metformin Hcl	232	54
Lisinopril	Lisinopril	220	63
Albuterol Sulfate Hfa	Albuterol Sulfate	207	65
Amlodipine Besylate	Amlodipine Besylate	203	63
Zolpidem Tartrate	Zolpidem Tartrate	185	26
Losartan Potassium	Losartan Potassium	182	55
Allopurinol	Allopurinol	169	42
Hydrochlorothiazide	Hydrochlorothiazide	151	44
Rosuvastatin Calcium	Rosuvastatin Calcium	151	39
Alprazolam	Alprazolam	138	29
Tamsulosin Hcl	Tamsulosin Hcl	134	37
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	126	16
Pravastatin Sodium	Pravastatin Sodium	112	33
Gabapentin	Gabapentin	106	25
Doxycycline Hyclate	Doxycycline Hyclate	96	84
Trazodone Hcl	Trazodone Hcl	94	20
Simvastatin	Simvastatin	93	26
Prednisone	Prednisone	84	65
Fluticasone Propionate	Fluticasone Propionate	77	29
Ozempic	Semaglutide	74	14
Amoxicillin	Amoxicillin	71	61
Glipizide Er	Glipizide	71	19
Famotidine	Famotidine	70	22
Metformin Hcl Er	Metformin Hcl	69	15
Tramadol Hcl	Tramadol Hcl	69	14
Metoprolol Succinate	Metoprolol Succinate	65	17
Tizanidine Hcl	Tizanidine Hcl	64	21
Clonazepam	Clonazepam	61	11
Escitalopram Oxalate	Escitalopram Oxalate	55	17
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	54	15
Citalopram Hbr	Citalopram Hydrobromide	53	15
Synthroid	Levothyroxine Sodium	53	14
Azithromycin	Azithromycin	52	48
Diazepam	Diazepam	52	suppressed
Duloxetine Hcl	Duloxetine Hcl	52	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	52	17
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	50	suppressed
Sertraline Hcl	Sertraline Hcl	48	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	47	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	46	12
Trulicity	Dulaglutide	46	suppressed
Meloxicam	Meloxicam	43	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	43	40
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	41	18
Diclofenac Sodium	Diclofenac Sodium	41	suppressed
Finasteride	Finasteride	41	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	40	36
Glipizide	Glipizide	37	suppressed
Fenofibrate	Fenofibrate	36	suppressed
Montelukast Sodium	Montelukast Sodium	36	11
Valacyclovir	Valacyclovir Hcl	36	22
Irbesartan	Irbesartan	35	suppressed
Ibuprofen	Ibuprofen	34	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	33	15
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	32	suppressed
Lansoprazole	Lansoprazole	29	suppressed
Mirtazapine	Mirtazapine	28	suppressed
Furosemide	Furosemide	27	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	27	14
Carvedilol	Carvedilol	25	suppressed
Efavirenz-Emtric-Tenofov Disop	Efavirenz/Emtricit/Tenofovr Df	25	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	24	22
Paxlovid	Nirmatrelvir/Ritonavir	24	24
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Benazepril Hcl	Benazepril Hcl	23	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	23	suppressed
Januvia	Sitagliptin Phosphate	23	suppressed
Nystatin	Nystatin	23	16
Hydroxyzine Hcl	Hydroxyzine Hcl	22	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	22	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Cephalexin	Cephalexin	20	19
Fluoxetine Hcl	Fluoxetine Hcl	20	suppressed
Genvoya	Elviteg/Cob/Emtri/Tenof Alafen	20	suppressed
Lovastatin	Lovastatin	20	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	19	suppressed
Ezetimibe	Ezetimibe	19	suppressed
Jardiance	Empagliflozin	19	suppressed
Meclizine Hcl	Meclizine Hcl	19	12
Valsartan	Valsartan	19	suppressed
Dutasteride	Dutasteride	18	suppressed
Emtricitabine-Tenofovir Disop	Emtricitabine/Tenofovir (Tdf)	18	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	18	suppressed
Pregabalin	Pregabalin	18	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Triumeq	Abacavir/Dolutegravir/Lamivudi	18	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Mometasone Furoate	Mometasone Furoate	17	suppressed
Ofloxacin	Ofloxacin	16	16
Buspirone Hcl	Buspirone Hcl	15	suppressed
Indapamide	Indapamide	15	suppressed
Oxycodone Hcl	Oxycodone Hcl	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Rybelsus	Semaglutide	15	suppressed
Testosterone Cypionate	Testosterone Cypionate	15	suppressed
Colchicine	Colchicine	14	suppressed
Lorazepam	Lorazepam	14	suppressed
Mupirocin	Mupirocin	14	suppressed
Potassium Chloride	Potassium Chloride	14	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	14	suppressed
Carbinoxamine Maleate	Carbinoxamine Maleate	13	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	13	suppressed
Risperidone	Risperidone	13	suppressed
Abacavir	Abacavir Sulfate	12	suppressed
Descovy	Emtricitabine/Tenofov Alafenam	12	suppressed
Isentress	Raltegravir Potassium	12	suppressed
Lamivudine-Zidovudine	Lamivudine/Zidovudine	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Pramipexole Er	Pramipexole Di-Hcl	12	suppressed
Alendronate Sodium	Alendronate Sodium	11	suppressed
Complera	Emtricita/Rilpivirine/Tenof Df	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Glycopyrrolate	Glycopyrrolate	11	suppressed
Juluca	Dolutegravir/Rilpivirine	11	suppressed
Olmesartan-Amlodipine-Hctz	Olmesartan/Amlodipin/Hcthiazid	11	suppressed
Ramipril	Ramipril	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error